Upcoming Meetings: Arthritis Advisory Panel
This article was originally published in The Gray Sheet
Arthritis Advisory Panel: Future guidance on claims structure for drug, biologic and device treatment of osteoarthritis slated for Feb. 20 discussion at the Holiday Inn in Bethesda, Maryland. The meeting will be held from 8:00 a.m. to 5:00 p.m. For more information contact Kathleen Reedy or LaNise Giles at 301/443-5455...
You may also be interested in...
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway